Combination of | |
---|---|
Ethinylestradiol | Estrogen |
Norethisterone | Progestogen |
Clinical data | |
Trade names | Alyacen, Aranelle, Balziva, others |
Other names | EE/NET |
AHFS/ Drugs.com | Monograph |
MedlinePlus | a601050 |
License data | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider |
|
CompTox Dashboard ( EPA) |
Ethinylestradiol/norethisterone (EE/NET), or ethinylestradiol/norethindrone, is a combination birth control pill which contains ethinylestradiol (EE), an estrogen and norethisterone (NET), a progestin. [1] It is used for birth control, symptoms of menstruation, endometriosis, and menopausal symptoms. [1] [2] Other uses include acne. [1] It is taken by mouth. [1] Some preparations of EE/NET additionally contain an iron supplement in the form of ferrous fumarate. [3]
Side effects can include nausea, headache, blood clots, breast pain, depression, and liver problems. [2] Use is not recommended during pregnancy, the initial three weeks after childbirth, and in those at high risk of blood clots. [2] [4] It, however, may be started immediately after a miscarriage or abortion. [4] Smoking while using combined birth control pills is not recommended. [5] It works by stopping ovulation, making the uterus not suitable for implantation, and making the mucus at the opening to the cervix thick. [4]
This combination pill was approved for medical use in the United States in 1964. [6] It is on the World Health Organization's List of Essential Medicines. [7] It is available as a generic medication. [8] It is marketed under a large number of brand names. [9] In 2021, it was the 52nd most commonly prescribed medication in the United States, with more than 12 million prescriptions. [10] [11]
Combination of | |
---|---|
Ethinylestradiol | Estrogen |
Norethisterone | Progestogen |
Clinical data | |
Trade names | Alyacen, Aranelle, Balziva, others |
Other names | EE/NET |
AHFS/ Drugs.com | Monograph |
MedlinePlus | a601050 |
License data | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider |
|
CompTox Dashboard ( EPA) |
Ethinylestradiol/norethisterone (EE/NET), or ethinylestradiol/norethindrone, is a combination birth control pill which contains ethinylestradiol (EE), an estrogen and norethisterone (NET), a progestin. [1] It is used for birth control, symptoms of menstruation, endometriosis, and menopausal symptoms. [1] [2] Other uses include acne. [1] It is taken by mouth. [1] Some preparations of EE/NET additionally contain an iron supplement in the form of ferrous fumarate. [3]
Side effects can include nausea, headache, blood clots, breast pain, depression, and liver problems. [2] Use is not recommended during pregnancy, the initial three weeks after childbirth, and in those at high risk of blood clots. [2] [4] It, however, may be started immediately after a miscarriage or abortion. [4] Smoking while using combined birth control pills is not recommended. [5] It works by stopping ovulation, making the uterus not suitable for implantation, and making the mucus at the opening to the cervix thick. [4]
This combination pill was approved for medical use in the United States in 1964. [6] It is on the World Health Organization's List of Essential Medicines. [7] It is available as a generic medication. [8] It is marketed under a large number of brand names. [9] In 2021, it was the 52nd most commonly prescribed medication in the United States, with more than 12 million prescriptions. [10] [11]